WT1 and acute promyelocytic leukemia: Because other Wilms tumor cell lines with expression of WT1 were unavailable, the NB4 acute promyelocytic leukemia cell line, which demonstrates high levels of WT1 expression, was used to validate the association between shRNA knockdown of WT1 and decreased TERT expression (Figures S5 and S6).